Runners | Controls | |
---|---|---|
Sample size (n) | 42 | 42 |
Women (n) | 21 | 21 |
Age (years) | 46±13 | 46±12 |
Height (inches) | 67±5 | 67±5 |
Weight (lbs) | 149±24* | 170±42 |
Meds (n) | ||
BP lowering | 1 | 5 |
NSAIDs | 3 | 2 |
Aspirin | 1 | 1 |
Cholesterol lowering | 2 | 4 |
Oral contraceptives | 5 | 2 |
Family history of CVD (n) | 15 | 10 |
Race time (h:min) | 4:20±0:47 | – |
Running mileage | 40±16 | – |
Years run | 12±10 | – |
Marathons completed (n) | 16±30 | – |
Average vigorous exercise/day (h) | 2.0±1.1* | 0.6±0.6 |
Average moderate exercise/day (h) | 3.9±2.2 | 3.2±2.7 |
Block fruit (pts) | 18.7±4.2 | 16.8±4.5 |
Block meat (pts) | 11.5±5.4 | 13.1±5.8 |
*Significant difference between runners and controls (p<0.05).
BP, blood pressure; CVD, cardiovascular disease; NSAIDs, non-steroidal anti-inflammatory drugs.